Build AI agents without code using n8n's 400+ integrations to automate Gmail, Slack, and CRM tasks with ChatGPT-powered ...

Microsoft’s Xbox division is conducting big layoffs, as the company deals with abject failure of its Game Pass strategy.

Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

The best AI for live transfers. Learn how to optimize speed-to-lead, automate multi-channel follow-ups, and improve QA to maximize your ROI.

YouTube content creation often feels like a guessing game, but a new strategy empowers creators to use ChatGPT for data-driven success. The AI transforms instinct into evidence by analyzing competitor ...

Microsoft is sunsetting its long-abandoned SMS Organizer app. Users have started receiving notifications about the shutdown. It also recommended that users migrate their data to another app. Microsoft ...

EXCLUSIVE: Veteran literary scout Philippa Donovan wants to reverse engineer the books-to-screen market through her new business, Two Script Studio. The operation will create ‘reverse adaptations‘ to ...

In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

The app, which allows casts and crews to mark up and revise scripts digitally, has diverted more than 120 million sheets from production sets worldwide over the past three years. By Kirsten Chuba ...

Office Scripts in Excel Online provide a practical way to automate repetitive tasks and streamline workflows. By using TypeScript and the Excel Document Object Model (DOM), users can programmatically ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...